Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

STL.News

Primary endpoint of viral load change from baseline at day 11 was met for one of three doses; consistent effects of viral reduction seen at earlier time points Rate of…

The post Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting appeared first on STL.News.

Source link